Jump to content
GreaseSpot Cafe

Leaderboard

Popular Content

Showing content with the highest reputation on 11/07/2021 in all areas

  1. You mean, like scientists working their God-given mental abilities devising effective vaccines?
    2 points
  2. As I've said before......we are IN THE EARLY STAGES OF LEARNING about Covid-19 and upcoming variants. To that end, there will be new methods, new pills, and new therapeutic treatments being introduced to the FDA, CDC, and general public. Medical doctors and institutions from around the world are engaged to find better solutions. Pfizer is advancing in its experimental phase of a new antiviral pill for Covid-19. Pfizer says COVID-19 pill cut hospital, death risks by 90% *********** Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drug maker joined the race for an easy-to-use medication to treat the coronavirus. Currently most COVID-19 treatments require an IV or injection. Competitor Merck's COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it. Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible, after independent experts recommended halting the company's study based on the strength of its results. Once Pfizer applies, the FDA could make a decision within weeks or months. Since the beginning of the pandemic last year, researchers worldwide have been racing to find a pill to treat COVID-19 that can be taken at home to ease symptoms, speed recovery and keep people out of the hospital. Having pills to treat early COVID-19 "would be a very important advance," said Dr. John Mellors, chief of infectious diseases at the University of Pittsburgh, who was not involved in the Pfizer study. .......[snip]
    1 point
×
×
  • Create New...